| Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: a systematic review and meta-analysis G Butler-Laporte, A Lawandi, I Schiller, M Yao, N Dendukuri, ... JAMA internal medicine 181 (3), 353-360, 2021 | 322 | 2021 |
| Blood culture results before and after antimicrobial administration in patients with severe manifestations of sepsis: a diagnostic study MP Cheng, R Stenstrom, K Paquette, SN Stabler, M Akhter, AC Davidson, ... Annals of internal medicine 171 (8), 547-554, 2019 | 170 | 2019 |
| Association between caseload surge and COVID-19 survival in 558 US hospitals, March to August 2020 SS Kadri, J Sun, A Lawandi, JR Strich, LM Busch, M Keller, A Babiker, ... Annals of Internal Medicine 174 (9), 1240-1251, 2021 | 161 | 2021 |
| Adjunctive Daptomycin in the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Randomized, Controlled Trial MP Cheng, A Lawandi, G Butler-Laporte, S De l’Étoile-Morel, K Paquette, ... Clinical Infectious Diseases 72 (9), e196-e203, 2021 | 44 | 2021 |
| Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: a systematic review and meta-analysis. JAMA Intern Med. 2021; 181 … G Butler-Laporte, A Lawandi, I Schiller, M Yao, N Dendukuri, ... Epub 2021/01/16. https://doi. org/10.1001/jamainternmed. 2020.8876 PMID …, 2020 | 32 | 2020 |
| Suspected severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) reinfections: incidence, predictors, and healthcare use among patients at 238 US healthcare facilities, 1 … A Lawandi, S Warner, J Sun, CY Demirkale, RL Danner, M Klompas, ... Clinical Infectious Diseases 74 (8), 1489-1492, 2022 | 22 | 2022 |
| IDSA guidance and ESCMID guidelines: complementary approaches toward a care standard for MDR Gram-negative infections A Lawandi, C Yek, SS Kadri Clinical Microbiology and Infection 28 (4), 465-469, 2022 | 19 | 2022 |
| On the Treatment of Pneumocystis jirovecii Pneumonia: Current Practice Based on Outdated Evidence EG McDonald, G Butler-Laporte, O Del Corpo, JM Hsu, A Lawandi, ... Open forum infectious diseases 8 (12), ofab545, 2021 | 18 | 2021 |
| Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: a systematic review and meta-analysis. JAMA Intern Med 181: 353-360 G Butler-Laporte, A Lawandi, I Schiller, M Yao, N Dendukuri, ... | 18 | 2020 |
| Neither blood culture positivity nor time to positivity is associated with mortality among patients presenting with severe manifestations of sepsis: the FABLED cohort study K Paquette, D Sweet, R Stenstrom, SN Stabler, A Lawandi, M Akhter, ... Open Forum Infectious Diseases 8 (7), ofab321, 2021 | 16 | 2021 |
| Suspected SARS-CoV-2 reinfections: incidence, predictors, and healthcare use among patients at 238 US healthcare facilities, June 1, 2020-February 28, 2021 A Lawandi, S Warner, J Sun, CY Demirkale, RL Danner, M Klompas, ... Clin Infect Dis 74, 1489-92, 2021 | 11 | 2021 |
| Proton pump inhibitors versus histamine-2 receptor antagonists likely increase mortality in critical care: an updated meta-analysis TC Lee, MG Wilson, A Lawandi, EG McDonald The American Journal of Medicine 134 (3), e184-e188, 2021 | 9 | 2021 |
| Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled … MP Cheng, A Lawandi, G Butler-Laporte, K Paquette, TC Lee Trials 19, 1-9, 2018 | 8 | 2018 |
| Reliability of admission procalcitonin testing for capturing bacteremia across the sepsis spectrum: real-world utilization and performance characteristics, 65 US hospitals … A Lawandi, M Oshiro, S Warner, G Diao, JR Strich, A Babiker, C Rhee, ... Critical care medicine 51 (11), 1527-1537, 2023 | 6 | 2023 |
| Real-world time to positivity of 2 widely used commercial blood culture systems in patients with severe manifestations of sepsis: an analysis of the FABLED study G Butler-Laporte, CP Yansouni, K Paquette, A Lawandi, SN Stabler, ... Open Forum Infectious Diseases 7 (9), ofaa371, 2020 | 6 | 2020 |
| Low-dose trimethoprim-sulfamethoxazole for the treatment of pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison … ZN Sohani, G Butler-Laporte, A Aw, S Belga, A Benedetti, A Carignan, ... BMJ open 12 (7), e053039, 2022 | 4 | 2022 |
| Can financial rewards for stewardship in primary care curb antibiotic resistance? A Lawandi, SS Kadri The Lancet Infectious Diseases 21 (12), 1618-1620, 2021 | 4 | 2021 |
| Antibody tests have higher sensitivity at≥ 15 days after symptom onset and 99% specificity for detecting SARS-CoV-2 A Lawandi, RL Danner Annals of internal medicine 173 (10), JC57, 2020 | 4 | 2020 |
| In vitro synergy of β-lactam combinations against KPC-producing Klebsiella pneumoniae strains A Lawandi, G Leite, MP Cheng, B Lefebvre, J Longtin, TC Lee Journal of Antimicrobial Chemotherapy 74 (12), 3515-3520, 2019 | 4 | 2019 |
| Stability of biological activity of frozen β-lactams over time as assessed by time-lapsed broth microdilutions G Leite, A Lawandi, MP Cheng, T Lee Antibiotics 8 (4), 165, 2019 | 4 | 2019 |
